ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer’s disease (AD) and other neurodegenerative disorders, today announce ...
Business associations say they are "raising issues of transparency, exorbitant cost, supply chain impracticality and other ...
A new JavaScript framework is gaining attention with a direct challenge to the React-first mindset that has dominated ...
Can you scream your way to happiness? Maybe not, but the scream clubs popping up around the U.S. promise some relief. Manny ...
President Donald Trump's decision to replace Department of Homeland Security Secretary Kristi Noem gives him an opportunity ...
Fans of MILF cinema are about to get a heavy dose of perfection with Julia Fox’s latest film, a festival favorite featuring ...
Fenway Sports Group bought the Pittsburgh Penguins in 2021 for around $900 million. It is in the process of selling it for $1 ...
Chile's most right-wing president in over three decades, Jose Antonio Kast, was sworn in Wednesday on a promise to tackle surging rates of violent crime and carry out mass migrant ...
The Food and Drug Administation is approving a generic drug for a very rare genetic disorder, but not for autism. On Tuesday, ...
Nearly $100 million in state grant funding meant to help disadvantaged small businesses is drawing scrutiny after 5 INVESTIGATES found several questionable recipients and a lack of publicly available ...
In the rampant retaliatory attack led by Iran in the aftermath of the preemptive coordinated strikes on Tehran, Saudi Arabia’s state-owned oil company, Saudi Aramco, and the Ras Tanura refinery were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results